Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciaf198 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Grace Montepiedra und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: HIV Infections, Isoniazid, Antitubercular Agents, Tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
TB APPRISE (IMPAACT P1078), a Phase IV randomized, multi-country non-inferiority trial assessing the safety of 28 weeks of isoniazid preventive therapy (IPT) initiated during pregnancy (immediate IPT) versus deferring to week 12 postpartum (deferred IPT) in people with HIV on antiretroviral therapy, showed higher than expected hepatotoxicity. We investigated the potential roles of antiretrovirals, isoniazid, pharmacogenetics and other factors.
Methods
Hepatotoxicity was defined as Grade ≥3 liver enzyme elevations; or Grade ≥2 enzyme elevations with elevated bilirubin or symptomatic hepatitis. We performed Poisson regression of all-cause hepatotoxicity on study arm, antiretroviral regimen, pharmacogenetics of isoniazid and efavirenz metabolism (NAT2, CYP2B6) and other participant characteristics. Adjusted models included study arm and covariates with P < .25 in unadjusted models. Antiretroviral regimen and pharmacogenetics interactions with study arm were evaluated.
Results
All 945 pregnant participants with follow-up liver function measurements were on antiretrovirals (85% with efavirenz, 13% with nevirapine); 63 (6%) experienced hepatotoxicity events; 29 (6%) in immediate, and 34 (7%) in deferred arm; only 5 events (8%) occurred in pregnancy; 49 (78%) occurred between delivery and 24 weeks postpartum. Higher risk of hepatotoxicity was observed with nevirapine use in the immediate arm, but there was no difference by study arm in participants on efavirenz. Slow efavirenz metabolizers had increased risk of hepatotoxicity.
Conclusions
It is critical to monitor for hepatotoxicity in early postpartum, where there is higher risk compared to antepartum. ARV regimen and pharmacogenetics should also be considered in making decisions on when to initiate IPT in pregnant and postpartum populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Obstetrics and Gynaecology, Stellenbosch University, Cape Town, South Africa.
- FHI 360, Durham, North Carolina, USA.
- University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
- Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.
- Botswana Harvard AIDS Institute Health Partnership, Gaborone, Botswana.
ORCID-Profile: Grace Montepiedra, Lisa Aaron, Gaerolwe Masheto, Adriana Weinberg, Amita Gupta
Förderung
- NICHD NIH HHS
- NIAID NIH HHS
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIMH NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- International Maternal Pediatric Adolescent AIDS Clinical Trials Network
- National Institute of Mental Health
Zitieren
APA
Montepiedra, G., Aaron, L., Theron, G., McCarthy, K., Bradford, S., Chipato, T., Vhembo, T., Stranix-Chibanda, L., Wabwire, D., Masheto, G., Jean-Philippe, P., Sterling, T. R., Weinberg, A., Gupta, A., & IMPAACT P1078 TB APPRISE Study Team (2026). Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf198
Vancouver
Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, et al. Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf198
BibTeX
@article{Montepiedra2026,
author = {Montepiedra, Grace and Aaron, Lisa and Theron, Gerhard and McCarthy, Katie and Bradford, Sarah and Chipato, Tsungai and Vhembo, Tichaona and Stranix-Chibanda, Lynda and Wabwire, Deo and Masheto, Gaerolwe and Jean-Philippe, Patrick and Sterling, Timothy R and Weinberg, Adriana and Gupta, Amita and IMPAACT P1078 TB APPRISE Study Team, IMPAACT P1078 TB APPRISE Study Team},
title = {Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciaf198}
}
EUVIMED